Ryunosuke Kanamaru

5.1k total citations · 1 hit paper
99 papers, 4.1k citations indexed

About

Ryunosuke Kanamaru is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ryunosuke Kanamaru has authored 99 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 37 papers in Oncology and 20 papers in Cancer Research. Recurrent topics in Ryunosuke Kanamaru's work include Cancer-related Molecular Pathways (15 papers), Cancer therapeutics and mechanisms (10 papers) and Cancer, Hypoxia, and Metabolism (9 papers). Ryunosuke Kanamaru is often cited by papers focused on Cancer-related Molecular Pathways (15 papers), Cancer therapeutics and mechanisms (10 papers) and Cancer, Hypoxia, and Metabolism (9 papers). Ryunosuke Kanamaru collaborates with scholars based in Japan, United States and Canada. Ryunosuke Kanamaru's co-authors include Chikashi Ishioka, Hiroyuki Shibata, Shunsuke Kato, Kazunori Otsuka, Shuang-Yin Han, Wen Liu, Shuntaro Ikawa, Motonobu Osada, A Wakui and Masuo Obinata and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Ryunosuke Kanamaru

96 papers receiving 4.0k citations

Hit Papers

Understanding the function–structure and function–mutatio... 2003 2026 2010 2018 2003 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryunosuke Kanamaru Japan 25 2.4k 1.8k 801 553 548 99 4.1k
W P Bennett United States 15 2.4k 1.0× 2.8k 1.5× 1.1k 1.4× 614 1.1× 345 0.6× 17 4.5k
Jean Bénard France 38 2.6k 1.1× 1.8k 1.0× 973 1.2× 364 0.7× 357 0.7× 150 4.5k
Rufus S. Day United States 32 4.0k 1.7× 2.2k 1.2× 1.6k 2.1× 440 0.8× 550 1.0× 72 5.5k
Debabrata Banerjee United States 34 2.6k 1.1× 2.2k 1.2× 1.4k 1.8× 283 0.5× 375 0.7× 109 5.2k
Falk Hlubek Germany 25 3.4k 1.4× 2.5k 1.4× 1.4k 1.8× 649 1.2× 467 0.9× 30 5.1k
Anne W. Hamburger United States 29 2.7k 1.1× 2.2k 1.2× 764 1.0× 174 0.3× 334 0.6× 110 4.9k
L. A. Liotta United States 21 3.0k 1.3× 1.7k 0.9× 1.8k 2.3× 534 1.0× 264 0.5× 39 4.9k
Carrie Rinker‐Schaeffer United States 34 2.6k 1.1× 1.1k 0.6× 670 0.8× 719 1.3× 228 0.4× 73 3.8k
Laura K. Shawver United States 26 3.4k 1.4× 2.0k 1.1× 1.2k 1.5× 304 0.5× 239 0.4× 47 5.1k
Naomi Goldfinger Israel 50 4.3k 1.8× 3.2k 1.7× 1.5k 1.9× 279 0.5× 478 0.9× 93 6.2k

Countries citing papers authored by Ryunosuke Kanamaru

Since Specialization
Citations

This map shows the geographic impact of Ryunosuke Kanamaru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryunosuke Kanamaru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryunosuke Kanamaru more than expected).

Fields of papers citing papers by Ryunosuke Kanamaru

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryunosuke Kanamaru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryunosuke Kanamaru. The network helps show where Ryunosuke Kanamaru may publish in the future.

Co-authorship network of co-authors of Ryunosuke Kanamaru

This figure shows the co-authorship network connecting the top 25 collaborators of Ryunosuke Kanamaru. A scholar is included among the top collaborators of Ryunosuke Kanamaru based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryunosuke Kanamaru. Ryunosuke Kanamaru is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kambe, Mariko, et al.. (2011). Phase I study of irinotecan by 24-h intravenous infusion in combination with 5-fluorouracil in metastatic colorectal cancer. International Journal of Clinical Oncology. 17(2). 150–154. 3 indexed citations
2.
Yonezawa, Takayuki, Tada‐aki Kudo, Hong Wang, et al.. (2004). Activation Mechanism of c-Jun Amino-terminal Kinase in the Course of Neural Differentiation of P19 Embryonic Carcinoma Cells. Journal of Biological Chemistry. 279(35). 36616–36620. 15 indexed citations
3.
Kato, Shunsuke, Shuang-Yin Han, Wen Liu, et al.. (2003). Understanding the function–structure and function–mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis. Proceedings of the National Academy of Sciences. 100(14). 8424–8429. 626 indexed citations breakdown →
4.
Kato, Hideaki, Miki Fujimura, Toshihiro Kumabe, et al.. (2003). PTEN gene mutation and high MIB-1 labeling index may contribute to dissemination in patients with glioblastoma. Journal of Clinical Neuroscience. 11(1). 37–41. 40 indexed citations
5.
Yamaguchi, Kensei, Masahiro Tada, N Horikoshi, et al.. (2002). Phase II study of paclitaxel with 3-h infusion in patients with advanced gastric cancer. Gastric Cancer. 5(2). 90–95. 83 indexed citations
6.
Kobayashi, Kunihiko, M. Fukuoka, Kenji Takeuchi, et al.. (2002). Phase I studies of nogitecan hydrochloride for Japanese. International Journal of Clinical Oncology. 7(3). 177–186. 7 indexed citations
7.
Ishibashi, Satoru, Takahiro Mori, K. Sugawara, et al.. (2001). The Response of Combined Chemotherapy with Nedaplatin and 5-FU for Recurrent and Advanced Esophageal Carcinoma. Comparison with Cisplatin/5-FU Combination Therapy.. The Japanese Journal of Gastroenterological Surgery. 34(8). 1269–1276.
8.
Hanada, Masahito, Jun Ninomiya‐Tsuji, Motoko Ohnishi, et al.. (2001). Regulation of the TAK1 Signaling Pathway by Protein Phosphatase 2C. Journal of Biological Chemistry. 276(8). 5753–5759. 123 indexed citations
9.
Mukouyama, Yoh‐suke, Natsuko Chiba, Takahiko Hara, et al.. (2000). The AML1 Transcription Factor Functions to Develop and Maintain Hematogenic Precursor Cells in the Embryonic Aorta–Gonad–Mesonephros Region. Developmental Biology. 220(1). 27–36. 67 indexed citations
10.
Imran, Muhammad, Kazuo Kubota, Shunsuke Yamada, et al.. (1999). Sclerosing Mediastinitis: Findings on Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography. Clinical Nuclear Medicine. 24(5). 305–308. 20 indexed citations
11.
Shimodaira, Hideki, Hiroyuki Shibata, Takao Suzuki, et al.. (1998). Functional analysis of human MLH1 mutations in Saccharomyces cerevisiae. Nature Genetics. 19(4). 384–389. 111 indexed citations
12.
Kikuchi, Hiroaki, et al.. (1997). Features of DNA Oligonucleosomal Fragmentation in Human Tumor Cell Lines and Its Detection by Flow Cytometry: Utility and Limitations. Japanese Journal of Cancer Research. 88(1). 56–63. 8 indexed citations
13.
Arita, Daisaku, Mariko Kambe, Chikashi Ishioka, & Ryunosuke Kanamaru. (1997). Induction of p53‐independent Apoptosis Associated with G2M Arrest Following DNA Damage in Human Colon Cancer Cell Lines. Japanese Journal of Cancer Research. 88(1). 39–43. 35 indexed citations
14.
Ioritani, Naomasa, Koichi Kambe, Masaaki Kuwahara, et al.. (1996). Microscope Opened by Shock Waves on Cancer Cell Surfaces : Morphological and Functional Features. 9(2). 161–167. 3 indexed citations
15.
Uematsu, Fumiyuki, Shuntaro Ikawa, Hideaki Kikuchi, et al.. (1994). Restriction fragment length polymorphism of the human CYP 2E1 (cytochrome P450IIE1) gene and susceptibility to lung cancer. Pharmacogenetics. 4(2). 58–63. 91 indexed citations
16.
Uematsu, Fumiyuki, Hideaki Kikuchi, Masakichi Motomiya, et al.. (1991). Association between Restriction Fragment Length Polymorphism of the Human Cytochrome P450IIE1 Gene and Susceptibility to Lung Cancer. Japanese Journal of Cancer Research. 82(3). 254–256. 184 indexed citations
17.
Shibata, Hiroyuki, Ryunosuke Kanamaru, Toshiaki Sato, et al.. (1990). Increase in the Level of P‐Glycoprotein mRNA Expression in Multidrug‐resistant K562 Cell Lines Treated with Sodium Butyrate Is Not Accompanied with Erythroid Differentiation. Japanese Journal of Cancer Research. 81(12). 1214–1217. 11 indexed citations
18.
Kanamaru, Ryunosuke, et al.. (1989). Mechanism of action of the synthetic imidazole compound YM 534 on human promyelocytic leukemia line HL-60 cells.. PubMed. 4(2). 137–44. 1 indexed citations
19.
Ishioka, Chikashi, et al.. (1988). Inhibitory effects of prostaglandin A2 on c-myc expression and cell cycle progression in human leukemia cell line HL-60.. PubMed. 48(10). 2813–8. 42 indexed citations
20.
Kanamaru, Ryunosuke, et al.. (1988). The mechanism of action of quinocarmycin citrate (KW 2152) on mouse L1210 cells in vitro. Cancer Chemotherapy and Pharmacology. 22(3). 197–200. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026